Director/PDMR Shareholding

Spire Healthcare Group PLC
28 March 2024
 

28 March 2024

 

Spire Healthcare Group plc (the Company)

 

Exercise of Executive Share Plan awards

On 26 March 2024, Justin Ash and Jitesh Sodha, both Executive Directors of the Company, exercised their vested:

·    Long Term Incentive Plan awards in the Company that were granted on 25 March 2019 (the 2019 LTIP award). 2019 LTIP awards were subject to certain performance metrics that were measured over a three-year period and full details of the outcomes of these were reported in the Company's 2021 Annual Report and Accounts. On vesting in March 2022, the 2019 LTIP awards were subject to a further two-year holding period which ended in March 2024; and

·    Deferred Share Bonus Plan awards that were granted on 18 March 2021 (the 2021 DSBP award). 2021 DSBP awards were subject to a three-year holding period which ended on the third anniversary of the award being made.

 

Following the exercise by both Directors of their 2019 LTIP awards and 2021 DSBP awards over ordinary shares in the Company and after the satisfaction of taxes due, both decided to retain the balance of ordinary shares as follows:

 

 

Share plan and type of award

Shares vested and exercised

Shares retained following satisfaction of taxes due

Justin Ash

2019 LTIP (in the form of nil-cost options)

 

373,263

197,829

Justin Ash

 

2021 DSBP (in the form of nil-cost options)

 

97,251

51,543

Total number of shares retained

249,372

 

Following the transactions, Justin Ash holds 827,640 ordinary shares in the Company.

 

 

Share plan and type of award

Shares vested and exercised

Shares retained following satisfaction of taxes due

Jitesh Sodha

2019 LTIP (in the form of nil-cost options)

 

239,738

127,061

Jitesh Sodha

 

2021 DSBP (in the form of nil-cost options)

 

41,637

22,067

Total number of shares retained

149,128

 

Following the transactions, Jitesh Sodha holds 283,186 ordinary shares in the Company.

 

The exercise of a vested 2019 LTIP award by John Forrest and a vested Long Term Incentive Plan award that were granted on 18 March 2021 by Harbant Samra, both PDMRS of the Company, are disclosed below.

 

Notification and public disclosure of transaction by persons discharging managerial responsibility and persons closely associated with them

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

 

Justinian Joseph Ash

2

Reason for the notification

a)

Position/status

 

Chief Executive Officer

b)

Initial notification /Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

 

Spire Healthcare Group plc

b)

LEI

213800IBJPW3SE2RA350

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 1 pence each

 

GB00BNLPYF73

b)

Nature of the transaction

Exercise of nil-cost options over ordinary shares vesting under the Spire Healthcare Group plc Long Term Incentive Plan 2014.

 

Following the exercise by Mr Ash of his award over 373,263 ordinary shares and after the satisfaction of taxes due, a balance of 197,829 ordinary shares were transferred to him which he has retained.

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

 

373,263

 

 

d)

Aggregated information

- Aggregated volume

- Price

As above

e)

Date of the transaction

2024-03-26

f)

Place of the transaction

XLON

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

 

Jitesh Himatlal Sodha

2

Reason for the notification

a)

Position/status

 

Chief Financial Officer

b)

Initial notification /Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

 

Spire Healthcare Group plc

b)

LEI

213800IBJPW3SE2RA350

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 1 pence each

 

GB00BNLPYF73

b)

Nature of the transaction

Exercise of nil-cost options over ordinary shares vesting under the Spire Healthcare Group plc Long Term Incentive Plan 2014.

 

Following the exercise by Mr Sodha of his award over 239,738 ordinary shares and after the satisfaction of taxes due, a balance of 127,061 ordinary shares were transferred to him which he has retained.

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

 

239,738

 

 

d)

Aggregated information

- Aggregated volume

- Price

As above

e)

Date of the transaction

2024-03-26

f)

Place of the transaction

XLON

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

 

Justinian Joseph Ash

2

Reason for the notification

a)

Position/status

 

Chief Executive Officer

b)

Initial notification /Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

 

Spire Healthcare Group plc

b)

LEI

213800IBJPW3SE2RA350

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 1 pence each

 

GB00BNLPYF73

b)

Nature of the transaction

Exercise of nil-cost options over ordinary shares vesting under the Spire Healthcare Group plc Deferred Share Bonus Plan 2014.

 

Following the exercise by Mr Ash of his award over 97,251 ordinary shares and after the satisfaction of taxes due, a balance of 51,543 ordinary shares were transferred to him which he has retained.

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

 

97,251

 

 

d)

Aggregated information

- Aggregated volume

- Price

As above

e)

Date of the transaction

2024-03-26

f)

Place of the transaction

XLON

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

 

Jitesh Himatlal Sodha

2

Reason for the notification

a)

Position/status

 

Chief Financial Officer

b)

Initial notification /Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

 

Spire Healthcare Group plc

b)

LEI

213800IBJPW3SE2RA350

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 1 pence each

 

GB00BNLPYF73

b)

Nature of the transaction

Exercise of nil-cost options over ordinary shares vesting under the Spire Healthcare Group plc Deferred Share Bonus Plan 2014.

 

Following the exercise by Mr Sodha of his award over 41,637 ordinary shares and after the satisfaction of taxes due, a balance of 22,067 ordinary shares were transferred to him which he has retained.

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

 

41,637

 

 

d)

Aggregated information

- Aggregated volume

- Price

As above

e)

Date of the transaction

2024-03-26

f)

Place of the transaction

XLON

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

 

John Joseph Forrest

2

Reason for the notification

a)

Position/status

 

Chief Operating Officer

b)

Initial notification /Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

 

Spire Healthcare Group plc

b)

LEI

213800IBJPW3SE2RA350

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 1 pence each

 

GB00BNLPYF73

b)

Nature of the transaction

Exercise of nil-cost options over ordinary shares vesting under the Spire Healthcare Group plc Long Term Incentive Plan 2014.

 

Following the exercise by Mr Forrest of his award over 133,525 ordinary shares and after the satisfaction of taxes due, a balance of 70,768 ordinary shares were sold at £2.32.

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

£2.32

133,525

70,768

 

d)

Aggregated information

- Aggregated volume

- Price

As above

e)

Date of the transaction

2024-03-26

f)

Place of the transaction

XLON

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

 

Harbant Singh Samra

2

Reason for the notification

a)

Position/status

 

Deputy Chief Financial Officer

b)

Initial notification /Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

 

Spire Healthcare Group plc

b)

LEI

213800IBJPW3SE2RA350

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 1 pence each

 

GB00BNLPYF73

b)

Nature of the transaction

Exercise of nil-cost options over ordinary shares vesting under the Spire Healthcare Group plc Long Term Incentive Plan 2014.

 

Following the exercise by Mr Samra of his award over 59,589 ordinary shares and after the satisfaction of taxes due, a balance of 31,582 ordinary shares were transferred to him which he has retained.

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

 

59,589

 

 

d)

Aggregated information

- Aggregated volume

- Price

As above

e)

Date of the transaction

2024-03-26

f)

Place of the transaction

XLON

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings